Traduction de «access to professional » (Néerlandais → Français) :

This means that one person out of four who suffers from a mental disorder has no access to professional help.
Ainsi, une personne sur quatre qui souffre d’un trouble mental n’a pas accès à une assistance professionnelle.

In concrete terms, this means that out of a hundred individuals who suffer from a mental disorder, 33 seek professional help, whereas only 27 really do receive treatment. […] The fact that between 6 and 8 out of 10 of those who suffer from a mental disorder do not receive treatment suggests that the access to mental health care is littered with stumbling blocks that have an inhibiting effect, such as the attitude towards mental health, the availability of medical care, financial considerations or the extent to which individuals think they need help”. ) (Bruffaerts et al., 2004) 14
Concrètement, cela signifie que parmi 100 personnes qui souffrent d’un trouble mental, 33 demandent une assistance professionnelle et seules 27 reçoivent effectivement un traitement.[…] Le fait que 6 à 8 personne sur 10 souffrant d’un trouble mental ne reçoivent pas de traitement indique que l’accès aux soins de santé mentale est parsemé d’embûches qui exercent un effet inhibiteur, comme l’attitude vis-à-vis de la santé mentale, l’accessibilité aux soins, des

In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.
In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.

Patients should not stop taking Thelin until they speak to their health care professional. F or further information, contact the local Pfizer Country office (Pfizer country websites can be accessed at [http ...]
Patients should not stop taking Thelin until they speak to their health care professional.